Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00902278 · ClinicalTrials.gov registry record · NA
Immune Responses Induced by Different Licensed Influenza Vaccines
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT00902278 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 193 participants.
The verdict
NCT00902278, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
The goal of this research is to find out how the body's immune system responds to different manufacturer's "flu" vaccines.
Interventions
- BIOLOGICAL Fluzone
- BIOLOGICAL Afluria
- BIOLOGICAL Fluarix
- BIOLOGICAL Fluvirin
- BIOLOGICAL Flulaval
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2008-10 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00902278
The ClinicalTrials.gov registry entry for NCT00902278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Fluzone is the first listed.
NCT00902278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00902278 about?
NCT00902278 is a clinical study titled "Immune Responses Induced by Different Licensed Influenza Vaccines". The goal of this research is to find out how the body's immune system responds to different manufacturer's "flu" vaccines.
What is the current status of trial NCT00902278?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2008-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00902278?
The interventions under investigation include: Fluzone (BIOLOGICAL), Afluria (BIOLOGICAL), Fluarix (BIOLOGICAL), Fluvirin (BIOLOGICAL), Flulaval (BIOLOGICAL).
Who is sponsoring clinical trial NCT00902278?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.